Healthcare Services US

US Ketamine Clinics Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

US Ketamine Clinics Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.34 Bn Placeholder estimate
Estimate 2025 $1.44 Bn 37.3% of the global market
Projected 2034 $2.79 Bn 93.3% Adds $1.35 Bn over 9 forecast years
CAGR 2025–2034 7.6% Faster than 57% of 107 Healthcare Services markets here
Key players 5
  • US is 37.26% of the global market.
  • In North America, the largest is US (this report) at $1.44 Bn.
  • Fastest growing: Canada at 10.2% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.35 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Ketamine Clinics Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.34 Bn — —
2025 (base) $1.44 Bn +$101.9 Mn —
2026 (forecast) $1.55 Bn +$109.7 Mn +7.6%
2027 (forecast) $1.67 Bn +$118.0 Mn +15.8%
2028 (forecast) $1.80 Bn +$127.0 Mn +24.6%
2029 (forecast) $1.93 Bn +$136.6 Mn +34%
2030 (forecast) $2.08 Bn +$147.0 Mn +44.2%
2031 (forecast) $2.24 Bn +$158.2 Mn +55.2%
2032 (forecast) $2.41 Bn +$170.2 Mn +67%
2033 (forecast) $2.59 Bn +$183.1 Mn +79.7%
2034 (forecast) $2.79 Bn +$197.0 Mn +93.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

US Ketamine Clinics Market Analysis at a glance
Market size, 2025$1.44 Bn placeholder estimate
Forecast, 2034$2.79 Bn placeholder estimate
Growth (CAGR), 2025–20347.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTreatment, indication and end user (see all)
Key playersJohnson & Johnson, Klarity Health, Mindbloom, Nushama, Novamind (see all)
Active clinical trials50 in the USSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The US Ketamine Clinics Market Analysis Executive Summary

Ketamine clinics give ketamine or esketamine treatments under medical supervision for depression and other mental health conditions.

Key segments of the ketamine Clinics market include treatment (IV Ketamine, Intranasal Esketamine and Ketamine-Assisted Psychotherapy) and indication (Depression, PTSD and Chronic Pain).

Bar chart: US Ketamine Clinics market size, 2024–2034, placeholder estimates. $1.34 Bn in 2024, $1.44 Bn in 2025 and $2.79 Bn in 2034, 7.6% CAGR.
US Ketamine Clinics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

US Ketamine Clinics Market Dynamics

Market Growth Drivers

More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the ketamine Clinics market. Governments and employers are investing more in mental health care.

Opportunity

Digital tools, new drug classes and care built into primary care and workplaces give the ketamine Clinics market strong room to grow worldwide.

Market Restraints

Shortages of mental health professionals, limited insurance coverage, side effects and the need for long-term treatment hold back the ketamine Clinics market.

Competitive Landscape for Ketamine Clinics Market in US

The ketamine Clinics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Ketamine Clinics Market in US

Ketamine Clinics in the US: payment and research

Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).⁠[1] ClinicalTrials.gov lists 50 studies on Ketamine Clinics that are recruiting, active or about to start in the US.⁠[2] Suicide rate: 14.0 per 100,000 people in 2023, the latest WHO figure for the US.⁠[3]

[1] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

[2] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.

[3] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Licensing, quality standards and payment models from public and private payers shape how ketamine Clinics services are delivered and paid for in US. Government health programs and insurance coverage are key to access.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Ketamine Clinics right now, from free public sources.

Clinical trials

50 active trials in the US

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Johnson & Johnson 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Ketamine Clinics in context

The US compared

  • Suicide rate: 14.0 per 100,000 people (2023). World: 9.2 per 100,000 people (2023).[1]
  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[2]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[3]

[1] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 19 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 18 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.

Free data on this topic

Inside the US

Quick answers

Frequently asked questions

How big is the Ketamine Clinics market in the US?
Placeholder estimate: about $1.44 Bn in 2025, rising to about $2.79 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Ketamine Clinics market in the US growing?
Placeholder estimate: about 7.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Ketamine Clinics market report cover?
The report splits the market by treatment (IV Ketamine, Intranasal Esketamine, Ketamine-Assisted Psychotherapy), indication (Depression, PTSD, Chronic Pain, Anxiety) and end user (Hospitals, Clinics, Home Care, Corporate and Payer Clients).
Who are the key players in the Ketamine Clinics market?
Key players include Johnson & Johnson, Klarity Health, Mindbloom, Nushama and Novamind.
What is driving the Ketamine Clinics market?
More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the ketamine Clinics market. Governments and employers are investing more in mental health care.
How is healthcare paid for in the US?
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS). Source: Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
How many clinical trials on Ketamine Clinics are running in the US?
50 studies are recruiting, active or about to start in the US, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.
What does WHO report for the US?
Suicide rate: 14.0 per 100,000 people in 2023, the latest WHO figure. Source: WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 15 Nov 2026.
How many people in the US are 65 or older?
18.4% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 18 Nov 2026.
How much research is published on Ketamine Clinics?
PubMed lists 12 papers on Ketamine Clinics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Healthcare Services reports in US

See all

Related on mental health

See the topic